• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外研究尿毒症毒素的 pH 依赖性蛋白结合特性。

pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro.

机构信息

Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.

Institute for Protein Research, Osaka University, Yamadaoka 3-2, Suita, Osaka 565-0871, Japan.

出版信息

Toxins (Basel). 2021 Feb 4;13(2):116. doi: 10.3390/toxins13020116.

DOI:10.3390/toxins13020116
PMID:33557434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7914709/
Abstract

Protein-bound uremic toxins (PBUTs) are difficult to remove using conventional dialysis treatment owing to their high protein-binding affinity. As pH changes the conformation of proteins, it may be associated with the binding of uremic toxins. Albumin conformation at pH 2 to 13 was analyzed using circular dichroism. The protein binding behavior between indoxyl sulfate (IS) and albumin was examined using isothermal titration calorimetry. Albumin with IS, and serum with IS, p-cresyl sulfate, indole acetic acid or phenyl sulfate, as well as serum from hemodialysis patients, were adjusted pH of 3 to 11, and the concentration of the free PBUTs was measured using mass spectrometry. Albumin was unfolded at pH < 4 or >12, and weakened interaction with IS occurred at pH < 5 or >10. The concentration of free IS in the albumin solution was increased at pH 4.0 and pH 11.0. Addition of human serum to each toxin resulted in increased free forms at acidic and alkaline pH. The pH values of serums from patients undergoing hemodialysis adjusted to 3.4 and 11.3 resulted in increased concentrations of the free forms of PBUTs. In conclusion, acidic and alkaline pH conditions changed the albumin conformation and weakened the protein binding property of PBUTs in vitro.

摘要

蛋白质结合型尿毒症毒素(PBUTs)由于其与蛋白质的高亲和力而难以通过常规透析治疗去除。由于 pH 值改变了蛋白质的构象,因此它可能与尿毒症毒素的结合有关。使用圆二色性分析了 pH 值为 2 到 13 的白蛋白构象。使用等温滴定量热法研究了间苯硫酸(IS)与白蛋白之间的蛋白质结合行为。将 IS 与白蛋白、血清中的对甲酚硫酸盐、吲哚乙酸或苯硫酸以及血液透析患者的血清的 pH 值调节为 3 到 11,并使用质谱法测量游离 PBUTs 的浓度。当 pH 值 < 4 或 >12 时,白蛋白发生去折叠,当 pH 值 < 5 或 >10 时,与 IS 的相互作用减弱。在 pH 值为 4.0 和 11.0 时,白蛋白溶液中游离 IS 的浓度增加。将人血清添加到每种毒素中,在酸性和碱性 pH 值下会增加游离形式。将接受血液透析的患者的血清 pH 值分别调节至 3.4 和 11.3,导致游离形式的 PBUTs 浓度增加。总之,酸性和碱性 pH 值条件改变了白蛋白构象,并削弱了 PBUTs 在体外的蛋白质结合特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b82/7914709/cc807474f208/toxins-13-00116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b82/7914709/c509541f7d94/toxins-13-00116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b82/7914709/dae1b184857f/toxins-13-00116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b82/7914709/1fa280304585/toxins-13-00116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b82/7914709/cc807474f208/toxins-13-00116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b82/7914709/c509541f7d94/toxins-13-00116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b82/7914709/dae1b184857f/toxins-13-00116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b82/7914709/1fa280304585/toxins-13-00116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b82/7914709/cc807474f208/toxins-13-00116-g004.jpg

相似文献

1
pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro.体外研究尿毒症毒素的 pH 依赖性蛋白结合特性。
Toxins (Basel). 2021 Feb 4;13(2):116. doi: 10.3390/toxins13020116.
2
Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.使用结合竞争剂去除血液透析中的蛋白结合型尿毒症毒素。
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):394-402. doi: 10.2215/CJN.05240418. Epub 2019 Feb 12.
3
Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.在接受血液透析的患者中,通过用十六烷基固定化纤维素珠进行直接血液灌流吸附蛋白结合型尿毒症毒素。
Artif Organs. 2018 Jan;42(1):88-93. doi: 10.1111/aor.12961. Epub 2017 Jul 13.
4
The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.盐酸司维拉姆对肠道来源尿毒症毒素血清水平的影响:来自体外实验和多中心、双盲、安慰剂对照、随机临床试验的结果。
Toxins (Basel). 2019 May 17;11(5):279. doi: 10.3390/toxins11050279.
5
Exploring binding characteristics and the related competition of different protein-bound uremic toxins.探索不同蛋白结合型尿毒症毒素的结合特性及相关竞争性。
Biochimie. 2017 Aug;139:20-26. doi: 10.1016/j.biochi.2017.05.010. Epub 2017 May 17.
6
Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease.蛋白结合型尿毒症毒素与慢性肾脏病患者无症状性心功能障碍的关系。
Toxins (Basel). 2018 Dec 5;10(12):520. doi: 10.3390/toxins10120520.
7
Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.探索不同阶段慢性肾脏病患者及血液透析期间尿毒症毒素的蛋白结合情况。
Toxins (Basel). 2015 Sep 28;7(10):3933-46. doi: 10.3390/toxins7103933.
8
Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes.红细胞对蛋白结合型尿毒症毒素的选择性转运。
Toxins (Basel). 2019 Jul 1;11(7):385. doi: 10.3390/toxins11070385.
9
Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.通过高渗预稀释血液透析滤过从蛋白质结合中释放尿毒症潴留溶质。
ASAIO J. 2015 Jan-Feb;61(1):55-60. doi: 10.1097/MAT.0000000000000166.
10
Truncated domains of human serum albumin improves the binding efficiency of uremic toxins: A surface plasmon resonance and computational approach.人血清白蛋白截短结构域提高尿毒症毒素的结合效率:表面等离子体共振和计算方法。
Int J Biol Macromol. 2020 Jul 15;155:1216-1225. doi: 10.1016/j.ijbiomac.2019.11.089. Epub 2019 Nov 15.

引用本文的文献

1
Future of Uremic Toxin Management.尿毒症毒素管理的未来。
Toxins (Basel). 2024 Oct 28;16(11):463. doi: 10.3390/toxins16110463.
2
Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis.硫酸吲哚酚诱导的尿毒症性动脉粥样硬化中的巨噬细胞毒性和治疗策略。
Toxins (Basel). 2024 May 31;16(6):254. doi: 10.3390/toxins16060254.
3
Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease.转移负担:慢性肾脏病中蛋白结合尿毒症毒素清除策略综述

本文引用的文献

1
The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders.尿毒症毒素对脑血管和认知障碍的影响。
Toxins (Basel). 2018 Jul 22;10(7):303. doi: 10.3390/toxins10070303.
2
Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia.在肝衰竭加内毒素血症的双打击猪模型中评估先进器官支持(ADVOS)系统。
Intensive Care Med Exp. 2017 Dec;5(1):31. doi: 10.1186/s40635-017-0144-3. Epub 2017 Jul 4.
3
A systematic study of the effect of low pH acid treatment on anti-drug antibodies specific for a domain antibody therapeutic: Impact on drug tolerance, assay sensitivity and post-validation method assessment of ADA in clinical serum samples.
J Clin Med. 2024 Mar 1;13(5):1428. doi: 10.3390/jcm13051428.
4
Pruritus and protein-bound uremic toxins in patients undergoing hemodialysis: a cross-sectional study.血液透析患者的瘙痒与蛋白结合型尿毒症毒素:一项横断面研究。
Clin Kidney J. 2024 Jan 9;17(1):sfae007. doi: 10.1093/ckj/sfae007. eCollection 2024 Jan.
5
Detailing Protein-Bound Uremic Toxin Interaction Mechanisms with Human Serum Albumin in the Pursuit of Designing Competitive Binders.解析蛋白结合尿毒症毒素与人体血清白蛋白相互作用机制,设计竞争结合物。
Int J Mol Sci. 2023 Apr 18;24(8):7452. doi: 10.3390/ijms24087452.
6
Indoxyl sulfate impairs erythropoiesis by triggering apoptosis and senescence.硫酸吲哚酚通过触发细胞凋亡和衰老来损害红细胞生成。
Exp Biol Med (Maywood). 2022 Aug;247(15):1350-1363. doi: 10.1177/15353702221097320. Epub 2022 May 25.
7
In vitro assessment of the biocompatibility of chemically treated silicone materials with human lens epithelial cells.体外评估化学处理的硅橡胶材料与人眼晶状体上皮细胞的生物相容性。
Sci Rep. 2022 Mar 17;12(1):4649. doi: 10.1038/s41598-022-08443-2.
8
New Strategies for the Reduction of Uremic Toxins: How Much More We Know.降低尿毒症毒素的新策略:我们知道多少。
Toxins (Basel). 2021 Nov 24;13(12):837. doi: 10.3390/toxins13120837.
低pH酸处理对结构域抗体治疗药物特异性抗药抗体影响的系统研究:对临床血清样本中ADA的药物耐受性、检测灵敏度及验证后方法评估的影响
J Immunol Methods. 2017 Sep;448:91-104. doi: 10.1016/j.jim.2017.06.002. Epub 2017 Jun 16.
4
Exploring binding characteristics and the related competition of different protein-bound uremic toxins.探索不同蛋白结合型尿毒症毒素的结合特性及相关竞争性。
Biochimie. 2017 Aug;139:20-26. doi: 10.1016/j.biochi.2017.05.010. Epub 2017 May 17.
5
Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients.在血液透析患者中使用口服活性炭吸附剂AST-120持续降低蛋白结合尿毒症毒素并改善氧化应激。
Sci Rep. 2015 Sep 23;5:14381. doi: 10.1038/srep14381.
6
Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma.混合基质中空纤维膜用于从人血浆中去除蛋白结合毒素。
Biomaterials. 2013 Oct;34(32):7819-28. doi: 10.1016/j.biomaterials.2013.07.008. Epub 2013 Jul 19.
7
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins.心肾综合征:蛋白结合型尿毒症毒素的新兴作用。
Circ Res. 2012 Nov 9;111(11):1470-83. doi: 10.1161/CIRCRESAHA.112.278457.
8
Normal and pathologic concentrations of uremic toxins.正常和病态的尿毒症毒素浓度。
J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24.
9
Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin.两种硫酸酯结合型尿毒症毒素对甲酚硫酸酯和吲哚硫酸酯与人血清白蛋白结合的相互作用。
Drug Metab Dispos. 2012 Jul;40(7):1423-8. doi: 10.1124/dmd.112.045617. Epub 2012 Apr 18.
10
Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.用液相色谱/串联质谱法测定血液透析患者的蛋白结合型尿毒症毒素及其对内皮细胞 ROS 产生的影响。
Anal Bioanal Chem. 2012 Jun;403(7):1841-50. doi: 10.1007/s00216-012-5929-3. Epub 2012 Mar 25.